Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 3rd quarter

<< Previous

Bullboard Posts

Next >>

Comment by Donein25on Jun 25, 2024 3:31pm

183 Views

Post# 36105643

RE:RE:RE:RE:3rd quarter

very good point. I raised this very issue at AGM. As you undoubtedly noticed the most recent data showed a 5% decrease in CR across the board. We may see more of this CR adjustment in the near term, but i think once patients are retreated after a recurrence, then these CR #s should rebound back.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market